- Home
- PRTA vs MCBS Comparison
PRTA vs MCBS Comparison
Compare PRTA & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MCBS
- Stock Information
- Founded
- PRTA 2012
- MCBS 2006
- Country
- PRTA Ireland
- MCBS United States
- Employees
- PRTA N/A
- MCBS N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MCBS Major Banks
- Sector
- PRTA Health Care
- MCBS Finance
- Exchange
- PRTA Nasdaq
- MCBS Nasdaq
- Market Cap
- PRTA 809.8M
- MCBS 709.2M
- IPO Year
- PRTA N/A
- MCBS 2019
- Fundamental
- Price
- PRTA $6.58
- MCBS $29.76
- Analyst Decision
- PRTA Buy
- MCBS Hold
- Analyst Count
- PRTA 9
- MCBS 1
- Target Price
- PRTA $27.67
- MCBS $34.00
- AVG Volume (30 Days)
- PRTA 1.7M
- MCBS 51.2K
- Earning Date
- PRTA 08-07-2025
- MCBS 07-22-2025
- Dividend Yield
- PRTA N/A
- MCBS 3.07%
- EPS Growth
- PRTA N/A
- MCBS 30.91
- EPS
- PRTA N/A
- MCBS 2.58
- Revenue
- PRTA $137,935,000.00
- MCBS $143,775,000.00
- Revenue This Year
- PRTA N/A
- MCBS $16.00
- Revenue Next Year
- PRTA $119.20
- MCBS $31.75
- P/E Ratio
- PRTA N/A
- MCBS $11.60
- Revenue Growth
- PRTA 54.55
- MCBS 19.70
- 52 Week Low
- PRTA $4.32
- MCBS $24.24
- 52 Week High
- PRTA $25.42
- MCBS $36.15
- Technical
- Relative Strength Index (RSI)
- PRTA 59.96
- MCBS 66.42
- Support Level
- PRTA $5.96
- MCBS $29.64
- Resistance Level
- PRTA $6.59
- MCBS $30.47
- Average True Range (ATR)
- PRTA 0.38
- MCBS 0.57
- MACD
- PRTA 0.15
- MCBS 0.25
- Stochastic Oscillator
- PRTA 83.93
- MCBS 89.46
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.